NICE TA Adherence list September 2013 Drug Indication NICE Approval Release Date Formulary review Ocriplasmin Vitreomacular Traction Approved 23/10/2013 Yes Aflibercept ( Eylea) Wet-age related Approved 24/07/2013 Yes Macular degeneration Eltrombopag Idiopathic Approved 24/07/2013 Yes thrombocytopenia purpura Aripiprazole (oral) Bipolar Disorder Approved 24/07/2013 Yes (children 13yrs & over) Mirabegron Overactive Bladder Approved 26/06/2013 Yes Dapagliflozin Type2 diabetes Approved 26/06/2013 Yes Combination thearpy Rivaroxaban Pulmonary embolism & Approved 26/06/2013 Yes preventing recurrent venous thromboembolism Ranibizumab visual impairment Approved 22/05/2013 Yes caused by macular oedema secondary to retinal veil occlusion Kyphoplasty Vertebral Fractures Approved 25/04/2013 Yes Pirfenidone Idiopathic pulmonary Approved 24/04/2013 Yes fibrosis Abatacept RA (first TNF) Approved 24/04/2013 Yes Vertebroplasty Vertebral Fractures Approved 24/04/2013 Yes Omalizumab Asthma - over 12yo & Approved 24/04/2013 Yes adults Omalizumab Asthma - 6-11yo Approved 24/04/2013 Yes Colistimethate Cystic Fibrosis Approved 27/03/2013 Yes Sodium (pseudomonas lung infection)
NICE TA Adherence list September 2013 Drug Indication NICE Approval Release Date Formulary review Ocriplasmin Vitreomacular Traction Approved 23/10/2013 Yes Aflibercept ( Eylea) Wet-age related Macular degeneration Approved 24/07/2013 Yes Eltrombopag Idiopathic thrombocytopenia purpura Approved 24/07/2013 Yes Aripiprazole (oral) Bipolar Disorder (children 13yrs & over) Approved 24/07/2013 Yes Mirabegron Overactive Bladder Approved 26/06/2013 Yes Dapagliflozin Combination thearpy Type2 diabetes Approved 26/06/2013 Yes Rivaroxaban Pulmonary embolism & preventing recurrent venous thromboembolism Approved 26/06/2013 Yes Ranibizumab visual impairment caused by macular oedema secondary to retinal veil occlusion Approved 22/05/2013 Yes Kyphoplasty Vertebral Fractures Approved 25/04/2013 Yes Pirfenidone Idiopathic pulmonary fibrosis Approved 24/04/2013 Yes Abatacept RA (first TNF) Approved 24/04/2013 Yes Vertebroplasty Vertebral Fractures Approved 24/04/2013 Yes Omalizumab Asthma - over 12yo & adults Approved 24/04/2013 Yes Omalizumab Asthma - 6-11yo Approved 24/04/2013 Yes Colistimethate Sodium Cystic Fibrosis (pseudomonas lung infection) Approved 27/03/2013 Yes
NICE-TA-Adherence-Check-list-September-2013-HAST.docx